The crucial role of vascular permeability factor/vascular endothelial growth factor in angiogenesis: A historical review

British Journal of Haematology

Volumn 128, Issue 3, 2005, Pages 303-309

  Ribatti, Domenico ^a  

^a UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

Author keywords

Angiogenesis; History of medicine; Vascular endothelial growth factor; Vascular permeability factor

Indexed keywords

AG 013676; ANGIOGENIC FACTOR; AVASTATIN; BEVACIZUMAB; PROTEIN TYROSINE KINASE INHIBITOR; RECOMBINANT HUMAN VEGF165; RECOMBINANT VASCULOTROPIN; SEMAXANIB; SUNITINIB; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN ANTIBODY; VATALANIB;

ANGIOGENESIS; CANCER; CAPILLARY; CLINICAL TRIAL; FENESTRATION; HUMAN; ISCHEMIC HEART DISEASE; LIMB ISCHEMIA; PRIORITY JOURNAL; REVIEW; TUMOR VASCULARIZATION;

ANGIOGENESIS INDUCING AGENTS; ANGIOGENESIS INHIBITORS; HISTORY, 20TH CENTURY; HUMANS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; VASCULAR DISEASES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 13444261932     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2004.05291.x     Document Type: Review

References (63)

1. Bauters, C., Asahara, T., Zheng, L.P., Takeshita, S., Bunting, N., Ferrara, N., Symes, J.F. & Isner, J.M. (1994) Physiological assessment of augmented vascularity induced by VEGF in ischemic rabbit hindlimb. American Journal of Physiology, 267, H1263-H1271.
2. Carmeliet, P., Ferreira, V., Breier, G., Pollefeyet, S., Kiekens, L., Gertsenstein, M., Fahrig, M., Vandenhoeck, A., Harpal, K., Eberhardt, C., Declercq, C., Pawling, J., Moons, L., Collen, D., Risau, W. & Nagy, A. (1996) Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature, 380, 435-439.
3. Carmeliet, P., Dor, Y., Herbert, J.M., Fukumura, D., Brusselmans, K., Dewerchin, M., Neeman, M., Bono, F., Abramovitch, R., Maxwell, P., Koch, C., Ratcliffe, P., Moons, L., Jain, R.K., Collen, D., Keshert, E. & Keshet, E. (1998) Role of HIF-1α in hypoxia-mediated angiogenesis, cell proliferation and tumour angiogenesis. Nature, 394, 485-490.
4. Chin, K., Kurashima, Y., Ogura, T., Tajiri, H., Yoshida, S. & Esumi, H. (1997) Induction of vascular endothelial growth factor/vascular permeability factor by nitric oxide in human glioblastoma and hepatocellular cell lines. Oncogene, 15, 437-442.
5. Cobleigh, M.A., Langmuir, V.K., Sledge, G.W., Miller, K.D., Haney, L., Novotny, W.F., Reimann, J.D. & Vassel, A. (2003) A phase I/II dose-escalation trial of bevacizumab in previously treated metastatic breast cancer. Seminars in Oncology, 30, 117-124.
6. Connolly, D.T., Olander, J.V., Heuvelman, D., Nelson, R., Monsel, R., Siegel, N., Haymore, B.L., Leimgruber, R. M. & Feder, J. (1989) Human vascular permeability factor isolation from U937 cells. Journal of Biological Chemistry, 264, 20017-20024.
7. Dvorak, H.F. (1986) Tumors: wounds that not heal. Similarity between tumor stroma generation and wound healing. The New England Journal of Medicine, 315, 1650-1658.
8. Dvorak, H.F., Harvey, V.S., Estrella, P., Brown, L.F., Mc Donagh, J. & Dvorak, A.M. (1987) Fibrin containing gels induce angiogenesis: implication for tumor stroma generation and wound healing. Laboratory Investigation, 57, 673-686.
9. Dvorak, H.F., Sioussat, T.M., Brown, L.F., Berse, B., Nagy, JA., Sotrel, A., Manseau, E.J., Van de Water, L. & Senger, D.R. (1991) Distribution of vascular permeability (vascular endothelial growth factor) in tumors-concentration in tumor blood vessels. Journal of Experimental Medicine, 174, 1275-1278.
10. Eichmann, A., Corbel, C., Najaf, V., Vaigot, P., Breant, C. & Le Douarin, N.M. (1997) Ligand-dependent development of the endothelial and hemopoietic lineages from embryonic mesodermal cells expressing vascular endothelial growth factor receptor-2. Proceedings of the National Academy of Sciences of the United States of America, 94, 5141-5146.
11. Ferrara, N. & Henzel, W.J. (1989) Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochemical and Biophysical Research Communications, 161, 851-855.
12. Ferrara, N., Winer, J., Burton, T., Rowland, A., Siegel, M., Philipps, H.S., Terrel, T., Keller, G.A. & Levinson, A.D. (1993) Expression of vascular endothelial growth factor does not promote transformation but confers a growth advantage in vivo to Chinese hamster ovary cells. Journal of Clinical Investigation, 91, 160-170.
13. Ferrara, N., Cehn, H., Davis Smyth, T., Gerber, H.P., Nguyen, T.N., Peers, D., Chisholm, V., Hillan, K.J. & Schwall, R.H. (1998) Vascular endothelial growth factor is essential for corpus luteurn angiogenesis. Nature Medicine, 4, 336-340.
14. Ferrara, N., Carver-Moore, K., Chen, H., Dowd, M., Lu, L., O'Shea, K.S., Powell-Braxton, L., Hillan, K.J. & Moore, M.W. (1996) Heterozygous embryonic lethality induced by targeted inacitivation of the VEGF gene. Nature, 380, 439-442.
15. Folkman, J., Watson, K., Ingber, D. & Hanahan, D. (1989) Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature, 339, 58-61.
16. Garber, K. (2002) Angiogenesis inhibitors suffer new setback. Nature Biotechnology, 20, 1067-1068.
17. Hanahan, D. (1985) Heritable formation of pancreatic beta cell tumors in transgenic mice expressing recombinant insulin/simian virus 40 oncogene. Nature, 315, 115-122.
18. Hanahan, D. & Folkman, J. (1996) Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell, 86, 353-364.
19. Henry, T.D. & Abraham, J.A. (2000) Review of preclinical and clinical results with vascular endothelial growth factors for therapeutic angiogenesis. Current Interventional Cardiology Report, 2, 228-241.
20. Henry, T.D., Annex, B.H., McKendall, G.R., Azrin, M.A., Lopez, J.J., Giordano, F.J., Shah, P.K., Willerson, J.T., Benza, R.L., Berman, D.S., Gibson, C.M., Bajamonde, A., Rundle, A.C., Fine, J. & Mc Cluskey, E.R. (2003) The VIVA trial: vascular endothelial growth factor in ischemia for vascular angiogenesis. Circulation, 107, 1359-1365.
21. Inoue, M., Hager, J.H., Ferrara, N., Gerber, H.P. & Hanahan, D. (2002) VEGF-A has a critical, non redundant role in angiogenic switching and pancreatic beta cell carcinogenesis. Cancer Cell, 1, 193-202.
22. Jiang, B.H., Agani, F., Passaniti, A. & Semenza, G.L. (1997) V-SRC induces expression of hypoxia-inducible factor 1 (HIF-1) and transcription of genes encoding vascular endothelial growth factor and enolase 1: involvement of HIF-1 in tumor progression. Cancer Research, 57, 5328-5335.
23. Jin, K., Zhu, Y., Sun, Y., Mao, X.O., Xie, L. & Greenberg, D.A. (2002) Vascular endothelial growth factor (VEGF) stimulates neurogenesis in vitro and in vivo. Proceedings of the National Academy of Sciences of the United States of America, 99, 11946-11950.
24. Jussila, L. & Alitalo, K. (2002) Vascular growth factors and lymph angiogenesis. Physiological Reviews, 8, 673-700.
25. Kabbinavar, F., Hurwitz, H.I., Fehrenbacher, L., Meropol, N.J., Novotny, W.F., Lieberman, G., Griffing, S. & Bergsland, E. (2003) Phase II, randomized trial comparing bevacizumab plus fluorouracil (FU)/leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancer. Journal of Clinical Oncology, 21, 60-65.
26. Karkkainen, M.J., Haiko, P., Sainio, K., Partanen, J., Taipale, J., Petrova, T.V., Jeltsch, M., Jackson, D.G., Talikka, M., Rauvala, H., Betsholtz, C. & Alitalo, K. (2004) Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nature Immunology 5, 74-80.
27. Kech, P.J., Hauser, S.D., Krivi, G., Sanzo, K., Warren, T., Feder, J. & Connolly, D.T. (1989) Vascular permeability factor, an endothelial cell mitogen related to platelet derived growth factor. Science, 246, 1309-1312.
28. Kerbel, R.S., Viloria-Petit, A., Okada, F. & Rak, J. (1998) Establishing a link between oncogenes and tumor angiogenesis. Molecular Medicine, 4, 286-295.
29. Khaibullina, A.A., Rosenstein, J.M. & Krum, J.M. (2004) Vascular endothelial growth factor promotes neurite maturation in primary CNS neuronal cultures. Devlopmental Brain Research, 148, 59-68.
30. Kieser, A., Welch, H.A., Brandner, G., Marme, D. & Kolck, W. (1994) Mutant p53 potentiates protein kinase C induction of vascular endothelial growth factor expression. Oncogene, 9, 963-969.
31. Kim, K.J., Li, B., Winer, J., Armanini, M., Gillett, N., Phillips, H.S. & Ferrara, N. (1993) Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature, 362, 841-844.
32. Kondo, S., Asano, M. & Suzuki, H. (1993) Significance of vascular endothelial growth factor/vascular permeability factor for solid tumor growth and its inhibition by the antibody. Biochemical and Biophysical Research Communications, 194, 1234-1241.
33. Kondo, S., Asano, M., Matsuo, K., Ohmori, I. & Suzuki, H. (1994) Vascular endothelial growth factor/vascular permeability factor is detectable in the sera of tumor-bearing mice and cancer patients. Biochimica et Biophysica Acta, 1221, 211-214.
34. Kraft, A., Weindel, K., Ochs, A., Marth, C., Zmija, J., Schumacher, P., Unger, O., Marme, D. & Gastl, G. (1999) Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease. Cancer, 85, 178-187.
35. Kukk, E., Lymboussaki, A., Taira, S., Kaipainen, A., Jeltsch, V., Joukov, V. & Alitalo, K. (1996) VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development. Development, 122, 3829-3837.
36. Le Couter, J., Kowalski, J., Foster, J., Hass, P., Zhang, Z., Dillard-Telm, L, Frantz, G., Rangell, L., De Guzman, L., Keller, G.A., Peale, F., Gurney, A., Hilla, K.J. & Ferrara, N. (2001) Identification of an angiogenic mitogen selective for endocrine gland endothelium. Nature, 412, 877-884.
37. Leung, D.W., Cachianes, G., Kuang, W.J., Goeddel, D.V. & Ferrara, N. (1989) Vascular endothelial growth factor is a secreted angiogenic mitogen. Science, 246, 1306-1309.
38. Makinen, K., Manninen, H., Hedman, M., Matsi, P., Musssalo, H., Alhava, E. & Yla-Herrtuala, S. (2002) Increased vascularity detected by digital subtraction angiography after VEGF gene transfer to human lower limb artery: a randomized, placebo-controlled, double-blinded phase II study. Molecular Therapy, 6, 127-133.
39. Margolin, K., Gordon, M.S., Holmgren, E., Gaudreault, J., Novotny, W., Fyfe, G., Adelman, D., Stalter, S. & Breed, J. (2001) Phase I trial of intravenous recombinant humanized monoclonal antibody to vascular endothelial growth factor in combination with chemotherapy in patients with advanced cancer: pharmacologic and long-term safety data. Journal of Clinical Oncology 19, 851-856.
40. Meyer, M., Clauss, M., Lepple-Wienhues, A., Waltenberger, J., Augustin, H.G., Ziche, M., Lanz, C., Buttner, M., Rziha, H.J. & Dehio, C. (1999) A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediated angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinases. The EMBO Journal, 18, 363-374.
41. Miles, A.A. & Miles, E.M. (1952) Vascular reaction to histamine, histamine liberator, and leukotaxine in the skin of guinea pigs. Journal of Physiology, 118, 228-257.
42. Nissen, N.N., Polverini, P.J., Koch, A.E., Volin, M.V., Gamelli, R.L. & Di Pietro, L.A. (1998) Vascular endothelial growth factor mediates angiogenic activity during the proliferative phase of wound healing. American Journal of Pathology, 152, 1445-1452.
43. Nuefeld, G., Cohen, T., Gengrinovitch, S. & Poltorak, Z. (1999) Vascular endothelial growth factor (VEGF) and its receptors. FASEB Journal, 13, 9-22.
44. Pearlman, J.D., Hibberd, M.G., Chuang, M.L., Harada, K., Lopez, J.J., Gladstone, S.R., Friedman, M., Sellke, F.W. & Simons, M. (1995) Magnetic resonance mapping demonstrates benefits of VEGF-induced myocardial angiogenesis. Nature Medicine, 1, 1085-1089.
45. Pepper, M.S. (1997) Manipulating angiogenesis: from basic science to the bedside. Arterioscelerosis, Thrombosis and Vascular Biology 17, 605-619.
46. Pertovaara, L., Kaipainen, A., Mutsonen, T., Orpana, A., Ferrara, N., Saksela, O. & Alitalo, K. (1994) Vascular endothelial growth factor is induced in response to transforming growth factor-beta in fibroblastic and epithelia cells. Journal of Biological Chemistry, 269, 6271-6274.
47. Presta, L.G., Chen, H., O'Connor, S.J., Chisholm, V., Meng, Y.G., Krummen, L., Winkler, M. & Ferrara, N. (1997) Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders. Cancer Research, 57, 4593-4599.
48. Prewett, M., Huber, J., Li, Y., Santiago, A., O'Connor, W., King, K., Overholse, J., Hooper, A., Pytowski, B., Witte, L., Bohlen, P. & Hicklin, D.J. (1999) Antivascular endothelial growth factor receptor (fetal liver kinase 1) monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumors. Cancer Research, 59, 5209-5218.
49. Roberts, W.G. & Palade, G. (1995) Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. Journal of Cell Science, 108, 2369-2379.
50. Roberts, W.G. & Palade, G. (1997) Neovasculature induced by vascular endothelial growth factor is fenestrated. Cancer Research, 57, 765-772.
51. Schuh, A.C., Faloon, P., Hu, R.L., Bhimani, M. & Choi, K. (1999) In vitro hematopoietic and endothelial potential of flk-1 -/- embryonic stem cells and embryos. Proceedings of the National Academy of Sciences of the United States of America, 96, 2159-2164.
52. Senger, D.R., Galli, S.J., Dvorak, A.M., Perruzzi, C.A., Harvey, V.S. & Dvorak, H.F. (1983) Tumor cells secrete a vascular permeability factor that promotes accumulation of ascite fluids. Science, 219, 983-985.
53. 2-terminal amino acid sequence of guinea pig tumor-secreted vascular permeability factor. Cancer Research, 50, 1774-1778.
54. Senger, D.R., Brown, L., Claffey, K. & Dvorak, A. (1995) Vascular permeability factor, tumor angiogenesis and stroma generation. Invasion and Metastasis, 14, 385-394.
55. Shalaby, F., Ho, J., Stanford, W.L., Fisher, K.D., Schuh, A.C., Schwartz, L., Bernstein, N.A. & Rossant, J. (1997) A requirement for flk-1 in primitive and definitive hematopoiesis and vasculogenesis. Cell, 89, 981-990.
56. Shweiki, D., Itin, A., Soffer, D. & Keshet, E. (1992) Vascular endothelial cell growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature, 359, 843-845.
57. Smith, J.K., Mamoon, N.M. & Duhe, R.J. (2004) Emerging roles of targeted small molecule protein-tyrosine kinase inhibitors in cancer therapy. Oncology Research, 14, 175-225.
58. Storkebaum, E. & Carmeliet, P. (2004) VEGF: a critical player in neurodegeneration. Journal of Clinical Investigation, 113, 14-18.
59. Takeshita, S., Zheng, L.P., Brogi, E., Kearney, M., Pu, L.Q., Bunting, S., Ferrara, N., Symes, J.F. & Isner, J.M. (1994) Therapeutic angiogenesis. A single intra-arterial bolus of vascular endothelial growth factor augments neovascularization in a rabbit ischemic hind limb model. Journal of Clinical Investigation, 93, 662-670.
60. Takeshita, S., Tsurumi, Y., Couffinahl, T., Asahara, T., Bauters, C., Symes, J., Ferrara, N. & Isner, J.M. (1996) Gene transfer of naked DNA encoding for three isoforms of vascular endothelial growth factor stimulates collateral development in vivo. Laboratory Investigation, 75, 487-501.
61. Wood, J.M., Bold, C., Buchdunger, E., Cozens, R., Ferrari, S., Frei, J., Hofmann, F., Mestan, J., Mett, H., O'Reilly, T., Persohn, E., Rosel, J., Scnell, C., Stover, D., Theuer, A., Towbin, H., Wenger, F., Woods-Cook, K., Menrad, A., Siemiester, G., Schirner, M., Thierauch, K.C., Schneider, M.R., Drevs, J., Martiny-Baron, G. & Totzke, F. (2000) PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinase, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration. Cancer Research, 60, 2178-2189.
62. Yamamoto, Y., Toi, M., Kondo, S., Matsumoto, T., Suzuki, H., Kitamura, M., Tsuruta, K., Taniguchi, T., Okamoto, A., Mori, T., Yoshida, M., Ikeda, T. & Tominaga, T. (1996) Concentrations of vascular endothelial growth factor in the sera of normal controls and cancer patients. Clinical Cancer Research, 2, 821-826.
63. Yang, J.C., Harworth, L., Sherry, R.M., Hwu, P., Schwartzentruber, D.J., Topalian, S.L., Steinberg, S.M., Chen, H.X. & Rosemberg, S.A. (2003) A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer. The New England Journal of Medicine, 349, 427-434.